Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/08897077.2020.1787300 http://scihub22266oqcxt.onion/10.1080/08897077.2020.1787300 32697171!7444094!32697171     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Subst+Abus 2020 ; 41 (3): 269-274 Nephropedia Template TP {{tp|p=32697171|t=2020. Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic |pdf=|usr=}}{{32697171}} gab.com Text Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic JO: Subst Abus http://www.kidney.de/pget.php?&tw=1&pmid=32697171 #FOAvip Medications for opioid use disorder (MOUD), such as methadone and buprenorphine, are effective strategies for treatment of opioid use disorder (OUD) and reducing overdose risk. MOUD treatment rates continue to be low across the US, and currently, some evidence suggests access to evidence-based treatment is becoming increasingly difficult for those with OUD as a result of the 2019 novel corona virus (COVID-19). A major underutilized source to address these serious challenges in the US is community pharmacy given the specialized training of pharmacists, high levels of consumer trust, and general availability for accessing these service settings. Canadian, Australian, and European pharmacists have made important contributions to the treatment and care of those with OUD over the past decades. Unfortunately, US pharmacists are not permitted to prescribe MOUD and are only currently allowed to dispense methadone for the treatment of pain, not OUD. US policymakers, regulators, and practitioners must work to facilitate this advancement of community pharmacy-based through research, education, practice, and industry. Advancing community pharmacy-based MOUD for leading clinical management of OUD and dispensation of treatment medications will afford the US a critical innovation for addressing the opioid epidemic, fallout from COVID-19, and getting individuals the care they need. Twit Text FOAVip Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic ????Subst Abus http://www.kidney.de/pget.php?&tw=1&pmid=32697171 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32697171 #FOAvip English Wikipedia <ref>{{Cite pmid|32697171}}</ref> Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic #MMPMID32697171 Cochran G; Bruneau J; Cox N; Gordon AJ Subst Abus 2020[]; 41 (3): 269-274 PMID32697171show ga Medications for opioid use disorder (MOUD), such as methadone and buprenorphine, are effective strategies for treatment of opioid use disorder (OUD) and reducing overdose risk. MOUD treatment rates continue to be low across the US, and currently, some evidence suggests access to evidence-based treatment is becoming increasingly difficult for those with OUD as a result of the 2019 novel corona virus (COVID-19). A major underutilized source to address these serious challenges in the US is community pharmacy given the specialized training of pharmacists, high levels of consumer trust, and general availability for accessing these service settings. Canadian, Australian, and European pharmacists have made important contributions to the treatment and care of those with OUD over the past decades. Unfortunately, US pharmacists are not permitted to prescribe MOUD and are only currently allowed to dispense methadone for the treatment of pain, not OUD. US policymakers, regulators, and practitioners must work to facilitate this advancement of community pharmacy-based through research, education, practice, and industry. Advancing community pharmacy-based MOUD for leading clinical management of OUD and dispensation of treatment medications will afford the US a critical innovation for addressing the opioid epidemic, fallout from COVID-19, and getting individuals the care they need. |*Community Pharmacy Services[MESH] |*Opiate Substitution Treatment[MESH] |*Pharmacists[MESH] |*Scope of Practice[MESH] |Analgesics, Opioid/*therapeutic use[MESH] |Australia[MESH] |Betacoronavirus[MESH] |Buprenorphine/therapeutic use[MESH] |COVID-19[MESH] |Canada[MESH] |Coronavirus Infections[MESH] |Delivery of Health Care[MESH] |Health Services Accessibility[MESH] |Humans[MESH] |Methadone/therapeutic use[MESH] |Opioid-Related Disorders/*drug therapy[MESH] |Pandemics[MESH] |Pneumonia, Viral[MESH] |SARS-CoV-2[MESH] |United Kingdom[MESH]Medication treatment for opioid use disorder and community pharmacy: E(epmc).pdf DeepDyve Pubget Overpricing